HighTower Advisors
ETON icon

HighTower Advisors’s Eton Pharmaceutcials ETON Stock Holding History

HighTower Advisors’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$455K Buy
+18,423
New +$322K ﹤0.01% 2805

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

HighTower Advisors's ETON Position: Q1 2026 in Review

HighTower Advisors opened a new position in Eton Pharmaceutcials (ETON) in Q1 2026: 18,423 shares worth $455K. The stake represents ﹤0.01% of the portfolio and ranks #2805 among its holdings.

116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • HighTower Advisors held 18,423 shares of Eton Pharmaceutcials worth $455K as of Q1 2026.
  • Eton Pharmaceutcials was a new HighTower Advisors position in Q1 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #2805 holding.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.